PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY

Angiotensin II receptor antagonists (ARA) established their position recently duet to new indications above arterial hypertension (HT). These are chronic heart failure, history of myocardial infarction, atrial fibrillation and metabolic syndrome. Analysis of evidence basis, including recently publis...

Full description

Bibliographic Details
Main Authors: S. A. Boytsov, I. P. Kolos
Format: Article
Language:English
Published: Столичная издательская компания 2016-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1141
_version_ 1797232232163704832
author S. A. Boytsov
I. P. Kolos
author_facet S. A. Boytsov
I. P. Kolos
author_sort S. A. Boytsov
collection DOAJ
description Angiotensin II receptor antagonists (ARA) established their position recently duet to new indications above arterial hypertension (HT). These are chronic heart failure, history of myocardial infarction, atrial fibrillation and metabolic syndrome. Analysis of evidence basis, including recently published biggest international clinical studies, was performed in the article. Data demonstrate that ARA can be effectively and safely used in wide clinical practice for improvement of life quality and life prolongation in patients with HT.
first_indexed 2024-03-08T14:03:08Z
format Article
id doaj.art-75b89d21963742ceabdbf22b40457612
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-04-24T15:57:00Z
publishDate 2016-01-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-75b89d21963742ceabdbf22b404576122024-04-01T07:43:32ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-0144697510.20996/1819-6446-2008-4-4-69-751140PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPYS. A. Boytsov0I. P. Kolos1Russian Cardiology Research and Production Center of Rosmedtechnology, Tretya Cherepkovskaya ul. 15a, Moscow, 121552 RussiaRussian Cardiology Research and Production Center of Rosmedtechnology, Tretya Cherepkovskaya ul. 15a, Moscow, 121552 RussiaAngiotensin II receptor antagonists (ARA) established their position recently duet to new indications above arterial hypertension (HT). These are chronic heart failure, history of myocardial infarction, atrial fibrillation and metabolic syndrome. Analysis of evidence basis, including recently published biggest international clinical studies, was performed in the article. Data demonstrate that ARA can be effectively and safely used in wide clinical practice for improvement of life quality and life prolongation in patients with HT.https://www.rpcardio.online/jour/article/view/1141angiotensin ii receptor antagonistsace inhibitorsarterial hypertensionmyocardial infarctionatrial fibrillation
spellingShingle S. A. Boytsov
I. P. Kolos
PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
Рациональная фармакотерапия в кардиологии
angiotensin ii receptor antagonists
ace inhibitors
arterial hypertension
myocardial infarction
atrial fibrillation
title PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
title_full PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
title_fullStr PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
title_full_unstemmed PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
title_short PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
title_sort place of angiotensin ii receptor antagonists in arterial hypertension therapy
topic angiotensin ii receptor antagonists
ace inhibitors
arterial hypertension
myocardial infarction
atrial fibrillation
url https://www.rpcardio.online/jour/article/view/1141
work_keys_str_mv AT saboytsov placeofangiotensiniireceptorantagonistsinarterialhypertensiontherapy
AT ipkolos placeofangiotensiniireceptorantagonistsinarterialhypertensiontherapy